Omega Healthcare Investors (NYSE:OHI) Stock Gets Price Target Reduction from UBS Group

Omega Healthcare Investors (NYSE:OHI) had its price target cut by equities research analysts at UBS Group from $54.00 to $52.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the real estate investment trust’s stock. UBS Group’s price target indicates a potential upside of 15.02% from the company’s previous close.

Other equities research analysts have also issued reports about the company. Raymond James Financial reissued an “outperform” rating and set a $53.00 price objective on shares of Omega Healthcare Investors in a research note on Tuesday, October 6th. Mizuho boosted their target price on Omega Healthcare Investors from $45.00 to $46.00 and gave the stock a “neutral” rating in a research report on Monday, August 31st. Scotiabank cut their target price on Omega Healthcare Investors from $50.00 to $47.00 and set a “sector perform” rating on the stock in a research report on Thursday, June 18th. Barclays reduced their target price on Omega Healthcare Investors from $50.00 to $48.00 and set an “underweight” rating for the company in a report on Tuesday. Finally, Citigroup increased their price target on Omega Healthcare Investors from $52.00 to $58.00 and gave the company a “buy” rating in a research report on Tuesday, August 4th. Six research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $49.93.

Omega Healthcare Investors Stock Up 0.1%

NYSE:OHI traded up $0.04 during trading hours on Tuesday, reaching $45.21. 1,169,951 shares of the company’s stock were exchanged, compared to its average volume of 2,080,531. The company has a market capitalization of $13.70 billion, a P/E ratio of 16.15, a price-to-earnings-growth ratio of 1.79 and a beta of 0.53. Omega Healthcare Investors has a 12 month low of $39.26 and a 12 month high of $52.39. The business’s 50-day simple moving average is $46.51 and its two-hundred day simple moving average is $46.90.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.68. The firm had revenue of $328.25 million for the quarter, compared to analyst estimates of $266.97 million. Omega Healthcare Investors had a net margin of 66.96% and a return on equity of 15.76%. The firm’s quarterly revenue was up 16.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.77 earnings per share. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. As a group, sell-side analysts anticipate that Omega Healthcare Investors will post 3.12 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Omega Healthcare Investors

A number of hedge funds have recently modified their holdings of the stock. Amundi boosted its position in Omega Healthcare Investors by 100.4% during the second quarter. Amundi now owns 1,125,875 shares of the real estate investment trust’s stock valued at $53,682,000 after purchasing an additional 564,175 shares during the last quarter. Oxbow Advisors LLC acquired a new position in Omega Healthcare Investors in the 1st quarter worth about $7,373,000. Y Intercept Hong Kong Ltd increased its position in Omega Healthcare Investors by 351.4% in the 1st quarter. Y Intercept Hong Kong Ltd now owns 42,368 shares of the real estate investment trust’s stock worth $1,857,000 after purchasing an additional 32,982 shares during the last quarter. AlphaGrep UK Ltd purchased a new stake in shares of Omega Healthcare Investors during the 2nd quarter worth about $1,246,000. Finally, Greenland Capital Management LP purchased a new stake in shares of Omega Healthcare Investors during the 2nd quarter worth about $7,867,000. 65.25% of the stock is owned by institutional investors and hedge funds.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) focused on healthcare facilities, with an emphasis on skilled nursing and assisted living properties. The company owns or invests in healthcare real estate and leases its properties to operators that provide care and related services to residents.

Omega generally uses long-term, predominantly triple-net lease arrangements, under which tenants are responsible for many property-level expenses, including maintenance, insurance and taxes.